variables: 816990
Data license: CC-BY
This data as json
id | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
816990 | Bacteriologically confirmed pulmonary relapse tuberculosis cases tested for rifampicin resistance | relapse cases tested for rifampicin resistance | 2023-12-05 11:51:59 | 2024-07-25 22:54:10 | 2020-2022 | 6308 | { "unit": "relapse cases tested for rifampicin resistance", "numDecimalPlaces": 0 } |
0 | r_rlt_rel | grapher/tuberculosis/2023-11-27/drug_resistance_surveillance/drug_resistance_surveillance#r_rlt_rel | 2 | major | Number of bacteriologically confirmed pulmonary relapse tuberculosis cases tested for rifampicin resistance. Rifampicin is an antibiotic medication used primarily in the treatment of tuberculosis and other bacterial infections; it works by inhibiting the growth of bacteria. | Number of bacteriologically confirmed pulmonary relapse tuberculosis patients with test results for rifampicin. | [] |
int | [] |
fe4e7c0da91f821d34bd7b8831ab8fe9 | d6cf46969526bcafc20619068426eb07 |